Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes

AKINCI B., Demir T., ÇELTİK A., BARIŞ M. M., Yener S., ÖZCAN M. A., ...Daha Fazla

DIABETES RESEARCH AND CLINICAL PRACTICE, cilt.82, sa.2, ss.172-178, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 82 Sayı: 2
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.diabres.2008.07.014
  • Dergi Adı: DIABETES RESEARCH AND CLINICAL PRACTICE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.172-178
  • Anahtar Kelimeler: Gestational diabetes, Osteoprotegerin, Endothelial dysfunction, Carotid intima thickness, PAI-1, SINGLE NUCLEOTIDE POLYMORPHISM, CORONARY-HEART-DISEASE, INSULIN-RESISTANCE, MYOCARDIAL-INFARCTION, SUBCLINICAL ATHEROSCLEROSIS, FIBRINOLYTIC DYSFUNCTION, ENDOTHELIAL DYSFUNCTION, PLASMA OSTEOPROTEGERIN, PROMOTER REGION, BONE-DENSITY
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Circulating levels of osteoprotegerin (OPG) have been shown to be increased in patients with cardiovascular disorders and diabetes. The aim of this study was to determine serum OPG levels in women with previous gestational diabetes (GDM), and to investigate the relationship between OPG and carotid intima media thickness (IMT) and circulating cardiovascular risk factors.